Rating History for ImmunoCellular Therapeutics (IMUC) by Maxim Group

More Stocks Rated by Maxim Group | Latest Ratings for IMUC
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/11/2016 N/A Downgrade Hold
(Buy)		 N/A
(N/A)		 0.09
(0.22)		 144.44% Details